Charles Chaojie Zhang

Charles Chaojie Zhang is an experienced research scientist currently overseeing research and development at Theragene Pharmaceuticals since March 2015. Zhang manages daily scientific activities and collaborations while serving as a key representative for global regulatory submissions. Prior to this role, Zhang held positions as Associate Director Toxicologist at Purdue Pharma from October 2007 to December 2014, Principal Toxicologist at Boston Scientific Corp from May 2005 to October 2007, and Toxicologist at Lexicon Pharmaceuticals, Inc. from February 2004 to May 2005. Zhang holds a Ph.D. in Pharmacology from the University of Arkansas for Medical Sciences and a Master’s degree in Chemistry from the University of Arkansas at Little Rock.